Loading chat...
GA SB381
Bill
Status
Introduced
2/16/2016
Primary Sponsor
Bruce Thompson
Click for details
AI Summary
- Adds Chapter 52 to Title 31 of the Georgia code to regulate the administration, compounding, and importation of nonembryonic and nonfetal cellular material, including stem cells and immune cells not derived from human embryos or fetuses
- Permits autologous (self-derived) nonembryonic and nonfetal cells to be administered only by the individual or by a physician licensed by the Georgia Composite Medical Board, while explicitly prohibiting the administration of allogeneic (donor-derived) nonembryonic and nonfetal cells
- Allows drugs, medicines, or health products to be compounded using nonembryonic and nonfetal cells as a single ingredient or combined with other ingredients, and permits pharmacies performing such compounding to operate in Georgia
- Authorizes individuals to import autologous nonembryonic and nonfetal cell treatments into Georgia for personal use, provided the treatment was obtained legally in its jurisdiction of origin
- Prohibits regulatory entities from penalizing activities authorized under the chapter, but preserves professional licensing boards' authority to regulate procedures and does not shield practitioners from liability for failure to meet standard medical care
Legislative Description
"Nonembryonic and Nonfetal Cell Therapy Act"; provide regulations for administration, compounding, and importation of certain cellular material
Last Action
Senate Read and Referred
2/17/2016
Full Bill Text
No bill text available